With 2 weeks until Through the Looking Glass, I am so excited to share with you where the funds raised from the night will be going.
One of my favourite things about working with Melanoma Institute Australia is the freedom I am allowed to choose where I want the money to go.
Without further ado, researchers and doctors at Melanoma Institute Australia are developing a unique clinical trial that will use existing drugs to target rare genes in melanoma patients who have exhausted all other treatment options.
The MelMatch Trial will test patients for abnormal changes (called mutations) in the genes that cause melanoma. Researchers will then match up these mutated genes with existing drugs. Preliminary research suggests that these drugs – which are already on the market but not currently used to treat melanoma – will stop the mutations in the faulty genes from spreading.
The trial means patients won’t have to wait years for drug development as these therapies are already available.
However, as these treatments have only been used to treat other cancers and have never before been tested in melanoma, close monitoring of patients is vital.
With my most recent news, it is research and trials like this that give me hope. There are some very clever heads working together to provide more options for stage 4 patients.
Through the Looking Glass
An annual event dreamt up by Emma Betts of Dear Melanoma, a 24 year old living with Stage 4 Melanoma.
7pm Saturday 14 May
Mirra, Bridge Street FORTITUDE VALLEY
150pp (includes canapés, alcohol and entertainment)
Dress to impress (cocktail to formal)
Book now at Brisbane Tickets